Skip to main content

Table 4 Comparison of the number of prediabetic patients between the two studied groups

From: Amelioration of polycystic ovary syndrome-related disorders by supplementation of thymoquinone and metformin

Number of prediabetes patients

At the beginning of the study

After 3 months

After 6 months

P1

P2

P3

Group A (N = 104)

35 (33.6%)

27 (25.9%)

18 (17.3%)

0.29

0.023*

0.21

Group B (N = 103)

34 (33.0%)

26 (25.2%)

17 (16.5%)

0.26

0.017*

0.16

P

-----

0.92

0.89

   
  1. *Statistically significant
  2. P1, beginning of the study compared to after 3 months; P2, beginning of the study compared to after 6 months; P3, after 3 months compared to after 6 months